David A Edmondson1,2, Pingyu Xia1, Brandon Keehn3, and Ulrike Dydak1,2
1School of Health Sciences, Purdue University, West Lafayette, IN, United States, 2Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, United States, 3Department of Speech, Language, & Hearing Sciences, Purdue University, West Lafayette, IN, United States
Synopsis
Processing strengths or “islets of ability” associated with autism
spectrum disorder (ASD), especially in visual search, have been of continued
interest as they provide insight into how those with ASD perceive the world
around them. In
typically-developing (TD) individuals, region-specific concentrations of GABA
are associated with differences in attention and perception. ASD may be
associated with an excitatory-inhibitory imbalance, however, it remains unclear
how this may contribute to superior search abilities. To test this, 37 ASD and TD
children participated in a magnetic resonance spectroscopy study using
MEGA-semi-LASER to detect GABA concentrations in cortical regions associated
with attention and perception.
Introduction
Individuals
with autism spectrum disorder (ASD) excel at visual search, performing better
than their typically-developing (TD)
peers across the lifespan1. Evidence of augmented ASD search
superiority with increasing target-distractor similarity has been used to
support the hypothesis that enhanced perceptual functioning contributes to
faster search. Others have suggested that faster search may be due to
differences in the distribution of attention and attentional filtering rather than
enhanced lower-level perceptual processing. Thus, the precise mechanism
underlying superior search and the brain bases for this advantage remains
unknown. One model has hypothesized that ASD is associated with an imbalance of
glutamatergic and GABAergic signaling.2 In addition, inter-individual
differences in attention and perception in TD individuals are associated with
region-specific concentrations of GABA3,4 However, the contributions of atypical
GABAergic function to enhanced visual search abilities in ASD has not been
determined. To test this, we used magnetic resonance spectroscopy (MRS) to
measure GABA using MEGA-semi-LASER in the bilateral visual cortex (VIS), right temporal
parietal junction (TPJ), and right frontal eye fields (FEF).Methods
Twenty-three
children with high-functioning ASD (19 males, 4 females, Average Age = 11.7
years, SD = 1.2) and 14 TD children (10 males, 4 females, Average Age = 11.7,
SD = 1.5) participated. Participants completed multiple experimental paradigms
prior to scanning including a visual search task (VST)5. Participants’ task was to
indicate the presence or absence of a target (vertical line) embedded within
arrays of distractors (tilted lines) that varied in set size (18, 24, 36 items)
(Figure 1a,b). Search speed was
measured as reaction time (RT) to determine presence or absence of the target
item. The slopes (a measure of search efficiency, reflecting the RT cost of
each additional distractor) and y-intercepts (associated with non-search,
perceptual processes) of the RT x set size functions were calculated for target
present and absent conditions (Figure 1c). All scans were obtained on a 3T Siemens
Prisma MR Scanner at Purdue University. MEGA-semi-LASER6,7 (TE = 68ms, TR = 2000ms, Averages
= 128) was used to measure GABA, Glx, NAA and tCr (Cr + PCr) in the VIS (30mm x
30mm x 20mm), TPJ (30mm x 30mm x 20mm), and FEF (30mm x 30mm x 20mm)3 (Figure 2). Difference and Off spectra were quantified using LCModel8. Repeated measures ANOVAs were used to
assess differences between groups and regions of interest. Pearson correlation
tests and were used to assess relationships between metabolites and VST
parameters (RT(present & absent), y-intercept(present &
absent), and slope(present & absent)).Results
No
group differences were found between ASD and TD in any region of interest (ROI)
for GABA, Glx, and tCr. However, there was a significant main effect of group for
NAA, with ASD having lower NAA than TD (F(1,94) = 10.94, p = 0.001). While NAA
was, on average, lower for ASD than TD in all three ROIs, post-hoc Tukey test
suggests that NAA was significantly lower (p < 0.01) in the TPJ but not for
the FEF and VIS (Figure 3). No
differences in RT(present or absent) or other VST measures were
noted. In ASD, we found a negative association between GABA+ and slope(absent)
(r = -0.47, p = 0.047) in the FEF (Figure
4) while, in the VIS, NAA was positively correlated with slope(absent)
(r = 0.52, p = 0.02). No significant relationships were found in TD children
between metabolites or VST.Discussion
GABA concentrations in
the three ROIs were found to be similar in ASD versus TD, which supports
findings in other studies. Nonetheless, in the FEF, we found that as GABA
increases, VST performance improves for ASD, but not in TD, suggestive of
improved attentional filtering. We also found NAA, commonly believed to be a
neuronal marker for function, to be lower in ASD than TD across all three
regions, but only significantly different in the TPJ, as has also been found by
others9–11. This
suggests that NAA, acting as a marker of neuronal function, may be
indicating a difference in GABAergic signaling efficiency in ASD due to
neuronal dysfunction.Conclusion
Together, our findings
are similar to prior reports, but suggest that autistic visual search
superiority may be due to differences in GABA signaling in the FEF. These
differences may be the underlying cause of improved visual search via improved
attentional filtering. Decreased NAA in ASD compared to TD may be linked to
dysfunctional GABA signaling, as has been found in animal models12. This may explain why average cortical GABA levels
do not differ between ASD and TD, but VST performance improves in relation to increased
GABA levels in ASD.Acknowledgements
This study was supported by a Purdue Neuroscience Pilot Grant and NIEHS F31 ES028081.References
- Kaldy
Z, Giserman I, Carter AS, Blaser E. The Mechanisms Underlying the ASD Advantage
in Visual Search. J Autism Dev Disord. 2016;46(5):1513-1527.
doi:10.1007/s10803-013-1957-x.
-
Hussman
JP. Suppressed GABAergic Inhibition as a Common Factor in Suspected Etiologies
of Autism. J Autism Dev Disord. 2001;31(2):247-248.
doi:10.1016/0002-9610(92)90118-B.
-
Sumner
P, Edden RAE, Bompas A, Evans CJ, Singh KD. More GABA, less distraction: a
neurochemical predictor of motor decision speed. Nat Neurosci.
2010;13(7):825-827. doi:10.1038/nn.2559.
-
Edden
RAE, Muthukumaraswamy SD, Freeman TCA, Singh KD. Orientation Discrimination
Performance Is Predicted by GABA Concentration and Gamma Oscillation Frequency
in Human Primary Visual Cortex. J Neurosci. 2009;29(50):15721-15726.
doi:10.1523/JNEUROSCI.4426-09.2009.
-
Kemner
C, Van Ewijk L, Van Engeland H, Hooge I. Brief report: Eye movements during
visual search tasks indicate enhanced stimulus discriminability in subjects
with PDD. J Autism Dev Disord. 2008;38(3):553-558.
doi:10.1007/s10803-007-0406-0.
-
Andreychenko
A, Boer VO, Arteaga De Castro CS, Luijten PR, Klomp DWJ. Efficient spectral
editing at 7 T: GABA detection with MEGA-sLASER. Magn Reson Med.
2012;68(4):1018-1025. doi:10.1002/mrm.24131.
-
MarjaĊska
M, Auerbach EJ, Valabrègue R, Van de Moortele P-F, Adriany G, Garwood M.
Localized 1H NMR spectroscopy in different regions of human brain in vivo at 7
T: T2 relaxation times and concentrations of cerebral metabolites. NMR
Biomed. 2012;25(2):332-339. doi:10.1002/nbm.1754.
-
Provencher
SW. Estimation of metabolite concentrations from localized in vivo proton NMR
spectra. Magn Reson Med. 1993;30(6):672-679. doi:10.1002/mrm.1910300604.
-
Kleinhans
NM, Schweinsburg BC, Cohen DN, Müller R-A, Courchesne E. N-acetyl aspartate in
autism spectrum disorders: regional effects and relationship to fMRI
activation. Brain Res. 2007;1162:85-97.
doi:10.1016/j.brainres.2007.04.081.
-
Hardan
AY, Fung LK, Frazier T, et al. A proton spectroscopy study of white matter in
children with autism. Prog Neuro-Psychopharmacology Biol Psychiatry.
2015;66:48-53. doi:10.1016/j.pnpbp.2015.11.005.
-
Carvalho
AP, Violante IR, Mouga S, Oliveira G, Castelo-Branco M. Medial Frontal Lobe
Neurochemistry in Autism Spectrum Disorder is Marked by Reduced
N-Acetylaspartate and Unchanged Gamma-Aminobutyric Acid and Glutamate +
Glutamine Levels. J Autism Dev Disord. 2018;48(5):1467-1482.
doi:10.1007/s10803-017-3406-8.
-
Horder
J, Andersson M, Mendez MA, et al. GABAA receptor availability is not altered in
adults with autism spectrum disorder or in mouse models. Sci Transl Med.
2018;10(461):eaam8434. doi:10.1126/scitranslmed.aam8434.